- Details
- Description
Pemrest (Pembrolizumab INN 100 mg/4 mL) is a prescription oncology immunotherapy medicine manufactured by Everest Pharmaceuticals Ltd., Bangladesh. It contains pembrolizumab, a humanized monoclonal antibody that works by blocking the PD-1 immune checkpoint, helping the body’s immune system recognize and fight cancer cells.
Pemrest is administered by intravenous (IV) infusion under the supervision of qualified healthcare professionals. Pembrolizumab is used in the treatment of several types of cancer, including certain cases of non-small-cell lung cancer, melanoma, head and neck cancer, gastric cancer, urothelial cancer, cervical cancer, and other cancers, depending on the patient's condition and approved treatment guidelines.
